Meet 23 of the ‘world’s best companies’ working in U.S. healthcare or health insurance

After assessing measures of revenue growth, employee satisfaction and attention paid to “ESG” issues, Time magazine and Statista are hailing 750 companies as the best in the world.

ESG stands for environmental stewardship, social justice and conscientious corporate governance.

Time suggests the 750 are setting the proverbial bar for taking care of investors, workers and planet Earth.

The rankings show “just who dominates the world economic order, with fast-moving tech and business-services companies unseating the manufacturers and consumer-goods companies that once drove the global economy,” Time economic correspondent Alana Semuels explains. “The world’s best companies of 2023 can make things, like their forefathers did, while their employees, shareholders and the planet profit, too.”

In order of ranking, here are the companies that are based in the U.S. and involved with healthcare or health insurance.
 

  1. Elevance Health (No. 17)
     
  2. Humana (No. 32)
     
  3. UnitedHealth (No. 48)
     
  4. Cigna (No. 69)
     
  5. Allstate (No. 173)
     
  6. Prudential (No. 181)
     
  7. Cardinal Health (No. 194)
     
  8. American International (No. 244)
     
  9. Travelers (No. 313)
     
  10.  Liberty Mutual (No. 317)
     
  11.  Progressive (No. 351)  
     
  12.  State Farm (No. 363)
     
  13.  MetLife (No. 377)
     
  14.  Centene (No. 668)
     
  15.  Kaiser Permanente (No. 423)
     
  16.  Fidelity National (No. 490)
     
  17.  Assurant (No. 507)
     
  18.  Hanover (No. 554)
     
  19.  Nationwide (No. 654)
     
  20.  Quest Diagnostics (No. 661)
     
  21.  Molina Healthcare (No. 714)
     
  22.  Guardian Life (No. 721)
     
  23.  Syneos Health (No. 746)
     

Browse the full list here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.